Learning to Inhale: Pulmonary Disease
Frank McCormack, UCHealth director of Pulmonary Critical Care and Sleep Medicine, led a research effort that identified the first effective therapy for LAM, a rare—but life-threatening—lung disease in women.
Lymphangioleiomyoma-tosis (LAM) is very much like a slow-moving cancer. A tumor develops somewhere in the body and the cells move to the lung. They infiltrate and secrete substances that dissolve portions of the lung. Seventy percent of LAM patients will have a collapsed lung at least once. It has the potential to destroy tissues and to kill.